Joe McCracken

Dr. McCracken has served as Savara’s lead independent director since December 2019 and as a member of the company’s Board of Directors since October 2013. Dr. McCracken currently advises biopharmaceutical companies on the design and implementation of corporate strategy and business development initiatives. He also serves on the Board of Directors of Lumos Pharma, Inc. and Modalis Therapeutics Corporation, as well as the Board of Directors of the privately held companies Regimmune Inc. and Neuropore Therapies, Inc. Previously, Dr. McCracken was Vice President and Global Head of Business Development and Licensing for Roche Pharma, a research-focused healthcare company, where he was responsible for global in-licensing and out-licensing activities. Prior to that he served as General Manager, Roche Pharma Japan and Asia Regional Head, Roche Partnering. Prior to Roche Pharma, Dr. McCracken held the position of Vice President, Business Development at Genentech, and previously held similar positions at Aventis Pharma and Rhone-Poulenc Rorer. Dr. McCracken holds a B.S. in Microbiology, a M.S. in Pharmacology, and a D.V.M. from The Ohio State University.